BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21340503)

  • 1. Incidence of type 2 diabetes by HbA1c and OGTT: the Isfahan Diabetes Prevention Study.
    Janghorbani M; Amini M
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S73-9. PubMed ID: 21340503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
    Borg R; Vistisen D; Witte DR; Borch-Johnsen K
    Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
    Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
    Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus.
    Mostafa SA; Davies MJ; Webb D; Gray LJ; Srinivasan BT; Jarvis J; Khunti K
    Diabet Med; 2010 Jul; 27(7):762-9. PubMed ID: 20636956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
    Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
    J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
    Valdés S; Botas P; Delgado E; Alvarez F; Díaz-Cadórniga F
    Diabetes Metab; 2011 Feb; 37(1):27-32. PubMed ID: 20934897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
    Inoue K; Matsumoto M; Akimoto K
    Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
    Gołembiewska E
    Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteria.
    Di Pino A; Scicali R; Calanna S; Urbano F; Mantegna C; Rabuazzo AM; Purrello F; Piro S
    Diabetes Care; 2014 May; 37(5):1447-53. PubMed ID: 24574348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
    Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
    Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study.
    Pajunen P; Peltonen M; Eriksson JG; Ilanne-Parikka P; Aunola S; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J; Lindström J;
    Diabet Med; 2011 Jan; 28(1):36-42. PubMed ID: 21166843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.
    Doerr R; Hoffmann U; Otter W; Heinemann L; Hunger-Battefeld W; Kulzer B; Klinge A; Lodwig V; Amann-Zalan I; Sturm D; Tschoepe D; Spitzer SG; Stumpf J; Lohmann T; Schnell O
    Diabetologia; 2011 Nov; 54(11):2923-30. PubMed ID: 21773683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
    Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
    Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shifting from glucose diagnostic criteria to the new HbA(1c) criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population.
    Costa B; Barrio F; Cabré JJ; Piñol JL; Cos FX; Solé C; Bolibar B; Castell C; Lindström J; Barengo N; Tuomilehto J;
    Diabet Med; 2011 Oct; 28(10):1234-7. PubMed ID: 21429007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HbA1c combined FPG on screening diabetes in health check-up.
    Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
    Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
    Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
    Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.